alithea – SKÅTAR ARCHITECTURE & DESIGN

LAB AUTOMATION

Machine learning for data
analysis automation

High throughput proteomics

THE PRECISION IMMUNOTHERAPY COMPANY

Alithea’s technology:
ZOOMASS™

Alithea’s technology ZOOMASS™ applies highly sensitive mass spectrometry to profile HLA-presented epitopes, the targets of T cells. Its specific focus is epitopes from specific genetic regions of interest.

The ZOOMASS™ technology distinguishes Alithea from competitor technology which typically apply standard proteomics methods that lack sensitivity if you are looking for specific antigens only.

ZOOMASS™ allows looking for tens of thousands of epitopes of interest, which was not possible before the development of ZOOMASS™.

Based on ZOOMASS™, Alithea has developed specific assays for:
- detecting neoepitopes on tumour cells with unprecedented sensitivity (NEOZOOM™) and for
- detecting epitopes from the specific genetic element of the question (CONZOOM™)

We develop precision medicine strategies